These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32464577)

  • 1. Left ventricular outflow tract pressure gradient changes after carvedilol-disopyramide cotherapy in a cat with hypertrophic obstructive cardiomyopathy.
    Hori Y; Fujimoto E; Nishikawa Y; Nakamura T
    J Vet Cardiol; 2020 Jun; 29():40-46. PubMed ID: 32464577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular geometric characteristics predict response to carvedilol in cats with asymptomatic hypertrophic obstructive cardiomyopathy caused by systolic anterior motion of the mitral valve.
    Mochizuki Y; Suzuki R; Yasumura Y; Saito T; Teshima T; Matsumoto H; Koyama H
    J Vet Med Sci; 2019 May; 81(5):734-738. PubMed ID: 30944272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mitral valve dysplasia in a cat causing reversible left ventricular hypertrophy and dynamic outflow tract obstruction].
    Kuijpers NW; Szatmári V
    Tijdschr Diergeneeskd; 2011 May; 136(5):326-31. PubMed ID: 21614848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L; Kilkenny E; Ferasin H
    J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Management (β Blocker ± Disopyramide) of Left Ventricular Outflow Gradient Secondary to Systolic Anterior Motion of the Mitral Valve After Repair.
    Kehl DW; Rader F; Pollick C; Trento A; Siegel RJ
    Am J Cardiol; 2016 Oct; 118(7):1053-6. PubMed ID: 27567136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
    Jung SW; Kittleson MD
    J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of responsiveness to disopyramide in patients with hypertrophic cardiomyopathy.
    Habib M; Hoss S; Bruchal-Garbicz B; Chan RH; Rakowski H; Williams L; Adler A
    Int J Cardiol; 2019 Dec; 297():75-82. PubMed ID: 31615649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
    Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol.
    Suzuki R; Mochizuki Y; Yuchi Y; Yasumura Y; Saito T; Teshima T; Matsumoto H; Koyama H
    BMC Vet Res; 2019 Oct; 15(1):376. PubMed ID: 31660967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mid-systolic drop in left ventricular ejection velocity in obstructive hypertrophic cardiomyopathy--the lobster claw abnormality.
    Sherrid MV; Gunsburg DZ; Pearle G
    J Am Soc Echocardiogr; 1997 Sep; 10(7):707-12. PubMed ID: 9339420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.
    Blass KA; Schober KE; Li X; Scansen BA; Bonagura JD
    J Vet Intern Med; 2014; 28(3):838-46. PubMed ID: 24597596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic left ventricular outflow and its mechanism in hypertrophic obstructive cardiomyopathy.
    Conklin HM; Huang X; Davies CH; Sahn DJ; Shively BK
    J Am Soc Echocardiogr; 2004 Apr; 17(4):375-83. PubMed ID: 15044873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of 2D speckle tracking imaging in evaluating the effect of percutaneous intramyocardial septal radiofrequency ablation in patients with hypertrophic obstructive cardiomyopathy.
    Qian D; Zhou X; Liu H; Cao L
    J Clin Ultrasound; 2021 Jul; 49(6):554-562. PubMed ID: 33675543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atenolol on heart rate, arrhythmias, blood pressure, and dynamic left ventricular outflow tract obstruction in cats with subclinical hypertrophic cardiomyopathy.
    Jackson BL; Adin DB; Lehmkuhl LB
    J Vet Cardiol; 2015 Dec; 17 Suppl 1():S296-305. PubMed ID: 26776587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
    Seo J; Payne JR; Novo Matos J; Fong WW; Connolly DJ; Luis Fuentes V
    J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
    Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
    Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
    Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
    J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
    Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
    J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.